drugset / Trial / NCT05461352
Long-Term Study of TS-142 in Patients with Insomnia
RandomizedParallel-groupOpen-labelTreatment
Summary
This is a randomized, open-label, multi-center long-term study in patients with insomnia.
Timeline
- Start
- 2022-10-11
- Primary completion
- 2024-03-07
- Completion
- 2024-03-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TS-142 | Small molecule | 5 mg | Oral |
| Subject | TS-142 | Small molecule | 10 mg | Oral |